Literature DB >> 30638946

Synergy of polymyxin B, tigecycline and meropenem against carbapenem-resistant Enterobacter cloacae complex isolates.

Paola Hoff Alves1, Roberta Taufer Boff2, Afonso Luis Barth3, Andreza Francisco Martins4.   

Abstract

Here, we evaluated the combinations of antibiotics polymyxin B (PMB), tigecycline (TGC) and meropenem (MEM) by time-kill curves (TKC) against carbapenem-resistant Enterobacter cloacae isolates. Combination of PMB/TGC and PMB/MEM showed promising results in sub-inhibitory concentration of PMB indicating the possibility of reducing the dose of PMB used in the treatment.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carbapenemases; Meropenem; Polymyxin B; Synergism; Tigecycline

Mesh：

Substances：

Year:  2018        PMID： 30638946     DOI： 10.1016/j.diagmicrobio.2018.11.011

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  8 in total

Review 1.  Current status of NDM-producing Enterobacterales in Brazil: a narrative review.

Authors:  Carlos Henrique Camargo
Journal:  Braz J Microbiol       Date:  2022-06-11       Impact factor: 2.214

2.  Multicenter Study of Carbapenemase-Producing Enterobacterales in Havana, Cuba, 2016-2021.

Authors:  Haiyang Yu; María Karla González Molina; Yenisel Carmona Cartaya; Marcia Hart Casares; Meiji Soe Aung; Nobumichi Kobayashi; Dianelys Quiñones Pérez
Journal:  Antibiotics (Basel)       Date:  2022-04-12

3.  Are Antimicrobial Peptide Dendrimers an Escape from ESKAPE?

Authors:  Yayoi Kawano; Olivier Jordan; Takehisa Hanawa; Gerrit Borchard; Viorica Patrulea
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-05-19       Impact factor: 4.730

4.  Molecular Epidemiology of and Risk Factors for Extensively Drug-Resistant Klebsiella pneumoniae Infections in Southwestern China: A Retrospective Study.

Authors:  Xiaolang Tian; Changwu Huang; Xiaoli Ye; Hongyan Jiang; Rufang Zhang; Xiaofang Hu; Dongshuang Xu
Journal:  Front Pharmacol       Date:  2019-11-01       Impact factor: 5.810

5.  Carbapenem-Resistant Enterobacter cloacae Causing Nosocomial Infections in Southwestern China: Molecular Epidemiology, Risk Factors, and Predictors of Mortality.

Authors:  Xiaolang Tian; Changwu Huang; Xiaoli Ye; Hongyan Jiang; Rufang Zhang; Xiaofang Hu; Dongshuang Xu
Journal:  Infect Drug Resist       Date:  2020-01-10       Impact factor: 4.003

6.  A Comparative Study of the Microbiological Efficacy of Polymyxin B on Different Carbapenem-Resistant Gram-Negative Bacteria Infections.

Authors:  Qiong Lu; Hai-Hong Zhu; Guo-Hua Li; Ting-Ting Qi; Liang-Jun Ye; Xin-Qi Teng; Qiang Qu; Ge-Fei He; Jian Qu
Journal:  Front Med (Lausanne)       Date:  2021-02-09

7.  Clinical Efficacy of Polymyxin B in Patients Infected with Carbapenem-Resistant Organisms.

Authors:  Qiong Lu; Guo-Hua Li; Qiang Qu; Hai-Hong Zhu; Yue Luo; Han Yan; Hai-Yan Yuan; Jian Qu
Journal:  Infect Drug Resist       Date:  2021-05-28       Impact factor: 4.003

8.  Carbapenem-resistant Enterobacter cloacae complex in a tertiary Hospital in Northeast China, 2010-2019.

Authors:  Jingjing Chen; Sufei Tian; Hua Nian; Ruixuan Wang; Fushun Li; Ning Jiang; Yunzhuo Chu
Journal:  BMC Infect Dis       Date:  2021-06-26       Impact factor: 3.090
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.